Atlas Trials

Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer

Clinical trial NCT03146637 · UNKNOWN

Trial details

NCT number
NCT03146637
Sponsor
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Liver Cancer
Start date
2017-05-01
Primary completion
2021-01-27
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.